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ABSTRACT
Objective: A novel series of substituted 3,3-diphenyl propanamide derivatives (I-VIII) were synthesized by reacting 3,3-diphenyl propanoyl chloride 
with different amines/amino acids, and all the derivatives were investigated for anthelmintic, antibacterial, and antifungal activity.
Methods: All the compounds were characterized by infrared (IR) and1H- nuclear magnetic resonance spectrometry data. The synthesized derivatives 
were investigated for their anthelmintic activity employing housefly worms method and earthworm species model. The antibacterial and antifungal 
activity was performed employing cup plate method.
Results: The synthesized compounds (VII and VIII) exhibited maximum anthelmintic activity as compared with standard drug albendazole at doses 
of 50 and 100 mg/mL, due to minimal paralyzing and death time in both housefly and earthworm models. The compounds (IV, VII, and VIII) at 
50 µg/mL exhibited maximum activity against Gram-negative bacterial strains, namely, Escherichia coli, Pseudomonas aeruginosa as compared with 
ciprofloxacin and same compounds exhibited maximum antifungal activity against Candida albicans and Aspergillus niger in comparison with standard 
drug griseofulvin at 50 µg/mL.
Conclusion: The synthesized compounds bearing amino acid moiety in their structure (VII-VIII) exhibited impressive anthelmintic activity in 
comparison with albendazole. This suggests that amino acid/peptide derivative of diphenyl propanamides can act as great anthelmintic agents. 
Further, the research can be performed to design potent antimicrobial diphenyl propanamide derivatives.
Keywords: 3,3-Diphenyl propanamide, Antibacterial, Antifungal, Anthelmintic.
INTRODUCTION
Inadequate novel antimicrobial agents and elevating bacterial 
resistance toward antimicrobials are a predominant topic in the field 
of drug development and studies [1,2]. Microbial infections have 
proliferated unexpectedly in the past 20 years due to antimicrobial 
resistance, intensification in impaired immune system patients 
due to HIV, cancer chemotherapy, and organ transplantation 
worldwide [3,4]. Despite noteworthy approach in the field of 
antimicrobial therapy, the increase in consumption and misuse of 
antibiotics have caused the emergence of bacterial resistance toward 
antibiotics [5,6]. In the present scenario, health problems demand to 
synthesize and investigate a novel class of antimicrobial agent proved 
to be active against microbes that are resistant toward currently used 
antibiotics [7]. TheJrefore, considering the pharmacological potential of 
aryl propioninc acid derivatives [8-12], novel derivatives of substituted 
3,3-diphenyl propanamide were synthesized and investigated for their 
antibacterial, antifungal, and anthelmintic activity against housefly 




Melting points were determined by the open capillary method and 
were uncorrected. IR spectra were recorded on a Shimadzu 8700 
Fourier-transform infrared spectrophotometer (Shimadzu, Japan) 
using KBr pellets. Nuclear magnetic resonance (1H-NMR) was recorded 
on a Bruker AC NMR spectrometer (300 MHz), (Bruker, USA) using 
CDCl3 as a solvent. Purity of all compounds was checked by thin-layer 
chromatography on pre-coated silica gel G plates (Kieselgel 0.25 mm, 
60G F254, Merck, Germany) using petroleum ether/ethyl acetate as 
developing solvent system in proportion (4:1) for compounds (I-V) 
and petroleum ether/ethyl acetate/ethanol in proportion (4:5:1) for 
compounds (VI-VIII). All the chemicals and solvents were purchased 
from Research Lab Fine Chem Industries, Mumbai, India.
Synthesis of 3,3-diphenyl propionic acid
Cinnamic acid (0.20 mol) and dry benzene (160 mL) were placed in a round 
bottom flask. Anhydrous aluminum chloride (40 g) was added slowly to the 
above solution and mixture was refluxed for 5 h. The excess of benzene 
was removed by steam distillation. The solid so obtained was collected by 
filtration, washed with water and recrystallized from absolute ethanol.
Synthesis of 3,3-diphenyl propanamide derivatives
3,3-diphenyl propionic acid (0.01 mol) was refluxed with 5 mL thionyl 
chloride for 1 h. Excess of thionyl chloride was removed by distillation, 
and 15 mL of diethyl ether was added to round bottom flask containing 
3,3-diphenyl propanoyl chloride and cooled over an ice bath. Substituted 
amine/amino acid (0.01 mol/0.02 mol) was dissolved in diethyl ether 
and cooled over an ice bath. Ethereal solution of 3,3-diphenyl propanoyl 
chloride was added dropwise to previously mentioned solution of 
substituted amine/amino acid. After the completion of this process, the 
substituted amide derivatives (I-VIII) were precipitated, respectively, 
collected by filtration than treated with dil. HCl washed with water and 
recrystallized from absolute ethanol. The list of synthesized compounds 
including their physicochemical properties is presented in Table 1, 
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reaction scheme is depicted in Scheme 1, and spectral characteristics of 
the synthesized derivatives are listed in Table 2.
Biological screening
Anthelmintic activity
Collection of Stomoxys calcitrans and earthworms
Houseflies (S. calcitrans) were trapped in a perforated sterile jar from 
recycling and waste disposable house of Moradabad Educational Trust 
Group of Institutions, Faculty of Pharmacy, Moradabad, Uttar Pradesh, 
India, and authentication was accomplished by Mr. Ramesh Kumar 
Gupta (Asst. Professor, Department of Pharmacology). The earthworms 
were collected from the soil of riverside at Ram Ganga Vihar, Moradabad, 
Uttar Pradesh, India.
Housefly worm medium preparation
The medium was prepared by adding (1.2 g) of beef extract powder 
in nutrient agar medium and pH was adjusted to 7.2 and sterilized in 
an autoclave (GPC Medical Ltd., Model AU201) at 121°C for 15 min. 
Amoxicillin (100 μg/mL) and clotrimazole (75 μg/mL) were added 
to the medium to prevent the growth of microbes. 20 mL/Petri dish 
of sterilized media were transferred to 60 Petri dishes and secured 
for solidification. Five matured female houseflies were placed inside 
the Petri dishes which were closed immediately and kept at room 
temperature. After 24 h, white colors eggs were hatched out by flies 
and died flies were removed. The Petri dishes were further cultured 
for the next 72 h evolving for the appearance of house fly worms. On 
generation of housefly worms, 20 worms from each dish were collected 
and weighed precisely in analytical balance to calculate the average 
weight of worm that was found to be 0.012 mg.
Preparation of drug solutions
Standard drug and compounds (I-VIII) were evaluated for anthelmintic 
potential at a concentration of 50 mg/mL and 100 mg/mL using 0.5% 
aq. solution of Tween 80 as a solvent.
Arraying of housefly worms
The cultured Petri dishes containing twenty S. calcitrans worms 
each were selected for anthelmintic activity [13], and dishes were 
categorized into different groups as follows. Group-A: Marked as 
(ABZ) for albendazole, consisting of 4 Petri dishes having 50 mg/mL, 
and other 4 different Petri dishes having 100 mg/mL concentrations 
of albendazole. Group-(B-I): Marked as I, II, III, IV, V, VI, VII, and VIII, 
respectively, consisting of 4 Petri dishes/concentrations of synthesized 
compounds similar to the concentrations of albendazole. Group-J: 
Table 1: List of synthesized compounds including their physicochemical properties
Compound R M.P. (°C) % yield Mol. weight (g/mol) Rf value
I 138–140 65 329 0.69
II 120–121 62 315 0.73
III 67–68 61 315 0.84
IV 98–99 67 353.78 0.59
V 110–112 63 335.79 0.65
VI 68–70 60 297.29 0.75
VII 108–109 61 373.29 0.86
VIII 126–128 65 363.29 0.77
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Scheme 1: Synthesis of 3,3-diphenyl propanamide derivatives. Reagent and condition (a) amines dissolved in diethyl ether and amino acid 
dissolved in 10% aq. NaOH
Marked as a control having 0.5% aq. solution of Tween 80, used in the 
same concentration as mentioned in the above two groups.
Estimation of anthelmintic activity with housefly worms
In each of the 8 Petri dishes/group, well having 1 cm diameter was bored 
with a borer at the center and for Group-A, 50 mg/mL of albendazole 
solution was poured in the well of first four Petri dishes of this group 
followed by adding 100 mg/mL of the same in last four Petri dishes of 
this group. The same technique was followed for pouring the solution of 
synthesized compounds (I-VIII) in their respective Groups-(B-I) along 
with Group-J, marked as a control. All the Petri dishes were incubated 
at 37°C. The worms were evaluated for motility. This was done after 
tapping the edges of Petri dishes and allowing the worms to move freely 
toward the well, the worms that were alive would be seen moving. After 
paralysis, the worms were not able to show any motion which can be 
observed clearly by eyes. The unparalyzed worms were trapped toward 
the well, and incubation process was carried out again. Group-J, Petri 
dishes worms were viable for approximately 15 days with no sign of 
paralysis and death. The results are enlisted in Table 3.
Estimation of anthelmintic activity using earthworm species
Anthelmintic activity studies for synthesized derivatives were carried out 
against three different species of earthworms, Megascolex konkanensis, 
(ICARBC 211), Pontoscotex corethruses (ICARBC 117), and Eudrilus eugeniea 
(ICARBC 042) following Garg and Atal method [14-17] at concentration 
of 50 mg/mL and 100 mg/mL, respectively, using 0.5% aq. solution of 
Tween 80. Three sets of Petri dishes with 4-inch diameter containing five 
earthworms of almost similar sizes/species (2 inches in length) in each 
set were prepared followed by categorization into three groups. Group-A: 
Marked as (ABZ) for albendazole having three sets (with respect to two 
different concentrations) each of three Petri dishes with three different 
earthworm species. Group-(B-I): Marked as I, II, III, IV, V, VI, VII, and VIII, 
respectively, having three sets (with respect to two different concentrations) 
each of the Petri dishes with five different earthworm species and Group-K: 
Marked as (C) for control having three sets (with respect to two different 
concentrations) each of three Petri dishes with five different earthworm 
species. The paralyzing and death time were noted, and their mean was 
calculated for each set. The death time was ascertained by placing the 
earthworms in warm water (50°C) which stimulated the movement if the 
worm was alive. The results are presented in Table 4.
Antibacterial and antifungal studies
The synthesized compounds (I-VIII) were screened for their 
antimicrobial activity by cup-plate diffusion method using the MHA 
medium [18-20]. The microorganisms selected for antibacterial 
activity were Bacillus subtilis (NCIM 2063), Staphylococcus aureus 
(NCIM 2079), Pseudomonas aeruginosa (NCIM 2034), and Escherichia 
coli (NCIM 2065) and fungal strains Candida albicans (MUCC 29), 
Aspergillus niger (MUCC 29), Microsporum audouinii (MUCC 545), and 
Trichophyton mentagrophytes (MUCC 665) were selected for antifungal 
activity. The synthesized compounds were tested at a concentration 
of 50 μg/mL. Ciprofloxacin for antibacterial activity and griseofulvin 
for antifungal activity were used as standard drugs at a concentration 
of 50 μg/mL. The results of antibacterial and antifungal studies were 
presented in Tables 5 and 6, respectively.
RESULTS AND DISCUSSION
The described research work comprises the synthesis of novel 
3,3-diphenyl propanamide derivatives. All the structures of novel 
synthesized derivatives were confirmed by IR and 1H-NMR spectral 
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analysis. Structure of derivatives (I-VIII) was confirmed by the 
appearance of bands at 3300–3350 cm−1 (-NH str., amide) and 
1690–1640 cm−1 (C=O str., amide) and presence of aromatic rings 
in structures of compounds was confirmed by strong out-of-plane 
deformation bands (C-H bending) at 886–820 cm−1. Moreover, the 
structures of compounds were also confirmed by the appearance of 
broad singlet at 7.80–7.25 ppm (for imino proton of CO-NH moiety) 
in 1H-NMR. The anthelmintic activity of synthesized compounds was 
tested against housefly worms and earthworm species. The results of 
anthelmintic activity were calculated on the basis of the time of paralysis 
and time of death as tabulated in Table 3, revealed that synthesized 
compounds (VII and VIII) exhibited good anthelmintic activity against 
housefly worms in dose-dependent manner, giving the shortest time 
of paralysis and death at 100 mg/mL. The standard drug, albendazole 
exhibited paralysis at 25.00±0.32 min and death at 36.10±0.14 min at 
a concentration of 50 mg/mL and 24.00±0.13 min, 35.00±0.11 min at 
100 mg/mL min, respectively. The compound VII at a concentration 
of 50 mg/ML causes paralysis at 24.45±0.10 min and death at 
35.40±0.70 min and 23.55±1.10 min, 34.32±0.24 min at 100 mg/mL, 
respectively. The compound VIII at a dose of 50 mg/mL causes paralysis 
at 24.30±0.65 min and death at 33.00±0.10 min and 23.45±0.14 min, 
34.20±0.65 min at 100 mg/mL, respectively. The results discovered that 
the compounds VII and VIII at both concentrations are more effective 
than albendazole due to minimized mean paralyzing and mean death 
time as compared to albendazole. The comparison of the results between 
these two derivatives disclosed that compound VIII is more potent than 
compound VII due to minimal mean paralysis and mean death time.
The results in Table 4 revealed the anthelmintic potential of synthesized 
compounds against earthworm species. The standard drug, albendazole 
in three earthworm species, namely M. konkanensis, P. corethruses, and 
E. eugeniea at dose of 50 and 100 mg/mL caused paralysis at 12.32±0.40, 
10.34±0.22, 13.10±0.10, 11.11±0.40, 12.15±0.12, and 10.54±0.10 min 
and death at 17.02±0.10, 14.10±0.25, 16.11±0.12, 14.35±0.22, 
16.45±0.14, and 14.10±0.20 min, respectively. The compounds VII and 
VIII in the same three earthworm species at a dose of 50 and 100 mg/mL 
declined the time of paralysis and death compared to that of albendazole. 
Therefore, it can be concluded that compounds VII and VIII are more 
effective anthelmintic agents than albendazole.
All the synthesized compounds (I-VIII) at dose of 50 µg/mL were 
screened for their antibacterial and antifungal activity by the 
cup-plate diffusion method using ciprofloxacin and griseofulvin 
as a standard drug at the same dose of 50 µg/mL. The results of 
antibacterial in Table 5 expressed that all the compounds exhibited 
moderate to good activity, against Gram-negative bacterial strains 
(E. coli and P. aeruginosa) and minimal potential against Gram-positive 
bacterial strains (B. subtilis and S. aureus). The compounds IV, VII, and 
VIII represented 4.5–13.6% higher activity against E. coli and 10–30% 
higher activity against P. aeruginosa in comparison to ciprofloxacin. 
Hence, it can be concluded that these derivatives exhibited maximum 
Table 2: Spectral characteristics of synthesized compounds
Compound IR (KBr, ν, cm−1), 1H-NMR (300 MHz, CDCl3, δ, ppm)
I 3500–3350 (N-H str.), 1600–1450 (C=C, str.), 900–
700 (C-H def.), 1690 (C=O), 1280–1278 (C-N str.), 
710–690 (C-H, def.). 6.8–7.2 (m, 3H, Ar-H), 7.31  
(s, 1H, NH), 2.18 (2H, CH2), 2.41 (s, 3H, CH3), 4.68 
δ (s, 1H, CH), 2.26 (s, 3H, CH3), 7.40 (s, 1H, -CONH)
II 3040–3000 (C-H aromatic str.), 1600–1550 (C=C, 
str.), 900–720 (C-H def.), 1682 (C=O), 3325 (NH str., 
amide). 6.8–7.2 (m, 15H, Ar-H), 7.31 (s, 1H, NH), 
2.18 (s, 2H, CH2), 4.68 (s, 1H, CH), 4.46 (s, 2H, CH2), 
7.20 (s, 1H, -CONH)
III 1690 (C=O), 1577–1495 (C=C, str.), 
3450–3300 (N-H str.), 3000 (C-H str.), 2.35 (s, 3H, 
CH3), 7.70 (s, 1H, -CONH), 6.5–7.5 (m, 14H, Ar-H), 7.25 
(s, 1H, NH), 4.52 (s, 2H, CH2)
IV 1639 (C=O str., amide), 1529 (N-H bend. amide), 
880–750 (C-H def.), 1670 (C=O), 6.2–7.5  (m, 13H, 
Ar-H), 4.52 (s, 1H, CH), 4.56 (s, 2H, CH2), 8.0(s, 1H, 
NH), 7.30 (s, 1H, -CONH)
V 3400–3350 (N-H str.), 880–750 (C-H def.), 
1670 (C=O), 6.3–7.0 (m, 14H, Ar-H), 7.8 (s, 1H, NH), 
4.25 (s, 1H, CH), 4.42 (s, 2H, CH2), 7.65  
(s, 1H, -CONH)
VI 3500–3350 (N-H str.), 3050–3000 (C-H aromatic 
str.), 1600–1450 (C=C, str.), 900–700 (C-H def.), 
1690 (C=O), 3000–2500 (OH, str.), 7.9 (s, 1H, NH), 
4.28 (s, 1H, CH), 4.35 (s, 2H, CH2), 7.60  
(s, 1H, -CONH), 11.0 (s, 1H, OH)
VII 1680 (C=O), 2995–2650 (OH str.), 3500–3330 (N-H 
str.), 4.64 (s, 1H, CH), 10.75 (s, 1H, OH), 1.43  
(s, 3H, CH3), 7.40 (s, 1H, -CONH), 2.80 (s, 1H, CH), 
8.10 (s, 1H, NH), 6.5–7.0 (m, 10H, Ar-H)
VIII 1675 (C=O str.), 1280–1275 (C-N str.), 
3000–2500 (O-H str.), 1600–1455 (C=C str.), 11.0  
(s, 1H, OH), 7.50 (s, 1H, -CONH), 8.10 (s, 1H, NH), 
7.10–7.16 (m, 10H, Ar-H), 4.25 (s, 2H, CH2)
Table 3: Anthelmintic activity of compounds against housefly worms
Group Concentration (mg/mL) Mean paralyzing time (min)a Mean death time (min)a
A (ABZ) 50 25.00±0.32 36.10±0.14
100 24.00±0.13 35.00±0.11
B (I) 50 26.21±0.15 39.00±0.10
100 25.20±0.18 37.12±0.25
C (II) 50 27.30±0.22 38.10±0.20
100 26.28±1.10 37.35±1.11
D (III) 50 28.15±0.20 38.26±0.20
100 27.10±0.10 37.40±0.17
E (IV) 50 26.25±1.25 39.15±0.11
100 25.25±0.15 36.10±1.15
F (V) 50 27.40±0.10 38.45±0.25
100 26.50±0.15 37.10±0.15
G (VI) 50 28.11±0.17 37.09±0.13
100 25.38±0.16 35.28±0.22
H (VII) 50 24.45±0.10 35.40±0.70
100 23.55±1.10 34.32±0.24
I (VIII) 50 24.30±0.65 33.00±0.10
100 23.45±0.14 34.20±0.65
J (C) 50 - -
100 - -
aData are given as mean±S.D
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Table 6: Antifungal activity of compounds
Compound Diameter of the zone of inhibition (mm)
Fungal strains
Candida albicans Microsporum audouinii Aspergillus niger Trichophyton mentagrophytes
I 18 16 16 15 
II 17 14 15 17 
III 19 17 18 13
IV 21 16 22 19 
V 20 13 17 16 
VI 18 15 18 18 
VII 22 17 24 20 
VIII 24 17 25 20 
Control - - - - 
Griseofulvin 20 18 19 21
Table 4: Anthelmintic activity of compounds against earthworm species
Group Concentration (mg/mL) Megascolex konkanensis Pontoscotex corethruses Eudrilus eugeniae
MPT (min)a MDT (min)a MPT (min)a MDT (min)a MPT (min)a MDT (min)a
A (ABZ) 50 12.32±0.40 17.02±0.10 13.10±0.10 16.11±0.12 12.15±0.12 16.45±0.14
100 10.34±0.22 14.10±0.25 11.11±0.40 14.35±0.22 10.54±0.10 14.10±0.20
B (I) 50 14.50±0.11 19.50±0.20 15.43±0.54 18.55±0.66 14.47±0.22 18.40±0.30
100 12.30±0.20 16.35±0.43 13.20±0.45 16.54±0.11 12.50±0.25 16.54±0.10
C (II) 50 15.20±0.20 19.40±0.10 15.40±0.45 19.10±0.50 14.27±0.11 18.55±0.20
100 12.55±0.10 16.55±0.35 13.10±0.25 17.24±0.20 12.45±0.10 17.05±0.15
D (III) 50 14.55±0.14 19.30±0.22 15.20±0.14 18.10±0.14 14.10±0.35 18.10±0.35
100 12.45±0.66 16.20±0.20 13.05±0.15 16.20±0.20 12.10±0.25 16.45±0.36
E (IV) 50 12.55±0.21 17.10±0.25 13.25±0.10 16.55±0.45 12.45±0.25 16.55±0.25
100 10.28±0.26 14.15±0.58 11.35±0.47 15.12±0.54 11.05±0.54 14.45±0.21
F (V) 50 14.05±0.21 19.05±0.15 14.40±0.42 17.40±0.44 13.35±0.21 17.25±0.65
100 12.10±0.20 15.45±0.12 12.45±0.25 15.50±0.10 12.05±0.10 15.24±0.16
G (VI) 50 12.40±0.14 17.45±0.15 13.35±0.10 16.25±0.14 12.45±0.13 17.10±0.11
100 10.55±0.10 14.20±0.25 11.25±0.10 15.25±0.25 11.10±0.45 14.40±0.14
H (VII) 50 12.10±0.10 16.55±0.24 12.75±0.10 16.10±0.15 12.15±0.10 16.40±0.20
100 10.25±0.25 13.75±0.54 10.45±0.48 14.34±0.25 10.42±0.10 13.65±0.15
I (VIII) 50 12.15±0.35 16.50±0.25 12.45±0.10 15.18±0.20 11.35±0.26 16.00±0.25
100 10.00±0.25 13.35±0.42 10.17±0.20 13.35±0.10 10.40±0.11 13.00±0.25
K (C) 50 - - - - - -
100 - - - - - -
aData are given as mean±S.D., MPT: Mean paralyzing time, MDT: Mean death time
Table 5: Antibacterial activity of compounds
Compound Diameter of the zone of inhibition (mm)
Bacterial strains
Bacillus subtilis Staphylococcus aureus Pseudomonas aeruginosa Escherichia coli
I 10 12 17 18
II 12 11 16 20 
III 16 14 17 17
IV 16 17 22 23
V 12 16 19 19
VI 13 13 21 17
VII 15 16 24 23
VIII 16 17 26 25
Control - - - -
Ciprofloxacin 17 18 20 22
activity against Gram-negative bacterial strains as compared to the 
standard drug. Table 6 expressed the results of antifungal activity of 
synthesized compounds and results revealed that all the compounds 
were more active against (C. albicans and A. niger) in comparison with 
M. audouinii and T. mentagrophytes and the compounds IV, VII, and VIII, 
exhibited 5-20% higher activity than griseofulvin against C. albicans 
and 15.78–31.5% higher activity against A. niger in comparison with 
standard drug griseofulvin.
CONCLUSION
This research demonstrated the synthesis of substituted 3,3-diphenyl 
propanamide derivatives. Anthelmintic activity was evaluated using 
housefly worms method and earthworm species model. The results of 
anthelmintic studies indicated good level of activity. The derivatives 
bearing amino acid moiety in the structure exhibited maximum 
anthelmintic, antibacterial, and antifungal activity. However, one fluoro, 
chloro substituted derivative represented maximum antibacterial and 
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antifungal activity in comparison with a standard drug. The findings 
suggested that amino acids derivatives of 3,3-diphenyl propanamide 
have magnificent future scope for further design and discovery as 
effective anthelmintics and antimicrobial agents.
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